The AI X Bio Summit 2026 @ NYSE - Applications Open
Decoding Bio’s fourth AI × Bio Summit will convene on July 23 at the New York Stock Exchange, gathering top pharma executives, AI‑first startups, and biotech investors. The agenda features a partnership panel between pharma and AI‑driven drug discovery firms, a discussion on late‑stage capital from crossover funds, and a forward‑looking talk from Frontier Labs on the evolving definition of a therapeutics company. Attendance is invitation‑only via an application process, with early‑bird tickets limited. Approved applicants receive a purchase link for the pass.
Scaling Bio 008: Serif Biomedicines' Jake Rubens on Turning Modified DNA Into a New Class of Medicine
In this episode, Jake Rubens of Serif Biomedicines explains how the company is turning DNA into a new class of medicines by using chemically modified DNA and a protein co‑factor to overcome DNA’s historic immunogenicity and delivery challenges. He contrasts...
Substack Live | Flagship Pioneering Announcement: Building on the Code of Life
Flagship Pioneering is hosting a Substack Live session on April 21 at 12:30 pm ET featuring origination partner Jake Rubens. The event will unveil a new initiative that leverages the "code of life" to advance synthetic‑biology‑based therapeutics. Rubens, an MIT‑trained synthetic biologist...
The Bioelectric Tech Stack
The episode frames biomanufacturing as a layer of the emerging electric tech stack, arguing that biology will become the chemical manufacturing layer that converts cheap electricity and feedstocks into high‑value molecules. It contrasts China’s systematic investment in the physical infrastructure—feedstock...